Senior insider sale
President and CEO at AMICUS THERAPEUTICS, INC. — senior position signals high conviction
$1.11M
107.10K shares
What this filing means
CAMPBELL BRADLEY L plans to sell 107.10K shares of AMICUS THERAPEUTICS, INC. valued at approximately $1.11M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/15/2025ACC: 0001950047-25-010349
DirectorOfficer· President and CEO
Since Mar 2026
107.10K
Shares to sell
$1.11M
Approx. market value
77.93K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
12/15/2025
70.43KRestricted and Performance Stock Units
N/A
12/31/2020
7.50KTotal acquired77.93K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2025 | Exercise of Stock Options Cash | 70.43K | — |
12/31/2020 | Restricted and Performance Stock Units N/A | 7.50K | — |
| Total | 77.93K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
14.59K
Market value
$146.0K
12/1/2025
—Completed
Units to sell
14.59K
Market value
$146.5K
11/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
77.93K
Market value
$822.1K
12/15/2025
Total
Units
107.10K
Value
$1.11M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/1/2025 | 14.59K | $146.0K | — | Completed |
11/24/2025 | 14.59K | $146.5K | — | Completed |
| Planned — Approximate Date | ||||
12/15/2025 | 77.93K | $822.1K | NASDAQ | Planned |
| Total | 107.10K | $1.11M | ||